$4700
The global wound care biologics market is expected to grow from USD 1.56 billion in 2019 to USD 3.34 billion by 2027, at a CAGR of 10.01% during the forecast period 2020-2027.
Wound care biologics are used to improve the process of healing of wounds through natural repair mechanisms. It involves the utilisation of active biological agents which provide antimicrobial and antioxidant properties. It helps to restore the tissue integrity and prevents loss of extracellular matrix proteins and contamination. It enables the wound to remain moist to avoid any wound closure barriers. They are getting popular for the treatment of burns and chronic wounds.
The increasing prevalence of chronic wounds with the rise in the number of cancer patients and diabetic patients, along with the rising incidences of accidents and burn cases will act as significant drivers for the growth of this market. With diabetes becoming common, more people face the problem of ulcers that require wound care biologics for efficient treatment. Also, the burn injuries which can easily catch a bacterial infection and need time for healing can be effectively treated with wound care biologics. The restraints for the growth of the market could be high cost and health risks related to the use of skin substitutes.
On the basis of wound type, the market can be segmented into diabetic foot ulcer, pressure ulcers, surgical & traumatic wound, and burns. Diabetic foot ulcers dominate the market share and is expected to grow at a rapid pace. High sugar levels cause diabetic wounds like foot ulcers which are effectively cured by wound care biologics. The pressure ulcer segment will also show a high growth rate owing to the rising prevalence of bedridden disorders, causing bedsores. Based on the type of products, the market can be divided into biological skin substitutes and topical agents. The biological skin substitutes are expected to dominate the market share in the segment. Biological skin substitutes ensure rapid healing of wounds and are mostly used for the treatment of burns. With the increase in the number of burn cases and other chronic diseases, the market share of biological skin substitutes will increase. Based on end-user, the market is divided into hospitals and clinics, ambulatory surgical centres (ASCs), and burn centres. Hospitals dominate the market share due to the high prevalence of chronic diseases and surgical wounds.
The market for wound care biologics market has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America is expected to hold the largest market share with a large number of cases of diabetic foot ulcer. Also, due to massive investments in the research and development of innovative technologies and the presence of leading players in the region, the market share will grow significantly. Asia-Pacific region is expected to show the highest growth rate with increasing investments in the healthcare infrastructure and innovation and rise in the number of patients.
Some of the leading players in the market are Health Care AB, Integra Life Sciences, MiMedx Group, Mölnlycke Health Care AB, Osiris Therapeutics, Derma Sciences, LifeSciences Corp., Smith & Nephew, Amnio Technology, Skye Biologics, Solsys Medica, and Wright Medical. The market is highly competitive, and the significant players adopt strategies like collaborations and, mergers and acquisitions. The companies are trying to focus on innovation with new product features, improved design, and better efficiency.
Global Wound Care Biologics Market Analysis And Forecast, By Wound Type
Global Wound Care Biologics Market Analysis And Forecast, By Product
Global Wound Care Biologics Market Analysis And Forecast, By End User
Global Wound Care Biologics Market Analysis And Forecast, By Regional Analysis
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Wound Type
4.3.2. Market Attractiveness Analysis By Product
4.3.3. Market Attractiveness Analysis By End User
4.3.4. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Global Wound Care Biologics Market Analysis and Forecast, By Wound Type
6.1. Segment Overview
6.2. Diabetic Foot Ulcer
6.3. Pressure Ulcers
6.4. Surgical & Traumatic Wound
6.5. Burns
7. Global Wound Care Biologics Market Analysis and Forecast, By Product
7.1. Segment Overview
7.2. Biological Skin Substitutes
7.3. Topical Agents
8. Global Wound Care Biologics Market Analysis and Forecast, By End User
8.1. Segment Overview
8.2. Hospitals and Clinics
8.3. Ambulatory Surgical Centres (ASCs)
8.4. Burn Centres
9. Global Wound Care Biologics Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Wound Care Biologics Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in Global Wound Care Biologics Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Health Care AB
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Integra Life Sciences
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. MiMedx Group
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Mölnlycke Health Care AB
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Osiris Therapeutics
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Derma Sciences
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. LifeSciences Corp.
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Smith & Nephew
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Amnio Technology
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Skye Biologics
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
11.11. SolsysMedica
11.11.1. Business Overview
11.11.2. Company Snapshot
11.11.3. Company Market Share Analysis
11.11.4. Company Product Portfolio
11.11.5. Recent Developments
11.11.6. SWOT Analysis
11.12. Wright Medical
11.12.1. Business Overview
11.12.2. Company Snapshot
11.12.3. Company Market Share Analysis
11.12.4. Company Product Portfolio
11.12.5. Recent Developments
11.12.6. SWOT Analysis
List of Table
1. Global Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
2. Global Diabetic Foot Ulcer Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
3. Global Pressure Ulcers Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
4. Global Surgical & Traumatic Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
5. Global Burns Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
6. Global Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
7. Global Biological Skin Substitutes, Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
8. Global Topical Agents, Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
9. Global Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
10. Global Hospitals and Clinics, Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
11. Global Ambulatory Surgical Centres (ASCs), Wound Care Biologics Market, By Region, 2017–2027 (USD Billion)
12. Global Burn Centres, Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
13. Global Wound Care Biologics Market, By Region, 2017–2027(USD Billion)
14. Global Wound Care Biologics Market, By North America, 2017–2027(USD Billion)
15. North America Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
16. North America Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
17. North America Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
18. U.S. Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
19. U.S. Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
20. U.S. Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
21. Canada Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
22. Canada Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
23. Canada Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
24. Mexico Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
25. Mexico Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
26. Mexico Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
27. Europe Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
28. Europe Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
29. Europe Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
30. Germany Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
31. Germany Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
32. Germany Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
33. France Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
34. France Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
35. France Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
36. U.K. Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
37. U.K. Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
38. U.K. Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
39. Italy Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
40. Italy Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
41. Italy Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
42. Spain Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
43. Spain Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
44. Spain Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
45. Asia Pacific Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
46. Asia Pacific Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
47. Asia Pacific Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
48. Japan Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
49. Japan Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
50. Japan Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
51. China Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
52. China Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
53. China Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
54. India Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
55. India Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
56. India Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
57. South America Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
58. South America Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
59. South America Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
60. Brazil Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
61. Brazil Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
62. Brazil Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
63. Middle East and Africa Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
64. Middle East and Africa Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
65. Middle East Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
66. UAE Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
67. UAE Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
68. UAE Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
69. South Africa Wound Care Biologics Market, By Wound Type, 2017–2027(USD Billion)
70. South Africa Wound Care Biologics Market, By Product, 2017–2027(USD Billion)
71. South Africa Wound Care Biologics Market, By End User, 2017–2027(USD Billion)
List of Figures
1. Global Wound Care Biologics Market Segmentation
2. Wound Care Biologics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Wound Care Biologics Market Attractiveness Analysis By Wound Type
9. Global Wound Care Biologics Market Attractiveness Analysis By Product
10. Global Wound Care Biologics Market Attractiveness Analysis By End User
11. Global Wound Care Biologics Market Attractiveness Analysis By Region
12. Global Wound Care Biologics Market: Dynamics
13. Global Wound Care Biologics Market Share By Wound Type (2020 & 2027)
14. Global Wound Care Biologics Market Share By Product (2020 & 2027)
15. Global Wound Care Biologics Market Share by End User (2020 & 2027)
16. Global Wound Care Biologics Market Share by Regions (2020 & 2027)
17. Global Wound Care Biologics Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –
Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance
Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.
Dear Siddhartha, The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us. Thanks for all your help!
Hi Siddhartha-san, Many thanks for sending trade map with final report. Best regards,
Hello Sapna,
Thanks for the report. We've been going through it and see some good data on the market and players.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.
IND